FDA Approved: FLUORODOPA F18 — Original Application (THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH)

View source ↗

Summary

FDA approved Fluorodopa F18 (FDOPA F-18) under an original application as a radiopharmaceutical for PET imaging of the brain's dopaminergic system.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• FLUORODOPA F18 (Fluorodopa F-18)

Snippet

ORIG AP for FLUORODOPA F18 (FLUORODOPA F18)